Skip to main content
Clinical Trials/NCT02394223
NCT02394223CompletedNot Applicable

Full Field Optical Coherence Tomography of Prostate Biopsies for the Diagnosis of Prostate Cancer

Assistance Publique - Hôpitaux de Paris1 site in 1 country91 target enrollmentStarted: January 27, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
91
Locations
1
Primary Endpoint
To evaluate the diagnosis performance of FFOCT for cancer detection in patients undergoing TRUS prostate biopsy, as compared to standard pathological evaluation

Study Overview

Brief Summary

Primary objective :

The primary objective is to evaluate the diagnosis performance of FFOCT for cancer detection in patients undergoing TRUS prostate biopsy, as compared to standard pathological evaluation.

Secondary objective:

  • Evaluate predictive values of FFOCT for cancer detection on prostate biopsy cores
  • Evaluate the value of FFOCT for cancer characterization on prostate biopsy cores
  • Evaluate the reproducibility of FFOCT evaluation for cancer detection on prostate biopsy cores
  • Evaluate the learning curve of FFOCT evaluation on prostate biopsy cores
  • Evaluate FFOCT procedure time

Detailed Description

Research in optical imaging has led to the development of the Full Field Optical Coherence Tomography (FFOCT) technology, which allows to image fresh tissues up to a depth of a few hundreds microns. The system is a microscope coupled with an interferometer. A halogen light source is used to illuminate the tissue specimen and a reference mirror. The light retro diffused by the specimen is combined with the light reflected by the mirror, and the interference signal is measured. Multiple Grey scale images are obtained and automatically stitched to obtain a complete slide throughout the specimen. The feasibility of the technique has been reported in various pilot studies, as well as the absence of any potential tissue harm and subsequent pathological artifact caused by the process.

FFOCT could be used as an additional detection tool for prostate cancer screening. The use of extended systematic trans-rectal ultrasound-guided (TRUS) prostate biopsies has led to over-diagnosis and over-treatment. Also, the number of unnecessary biopsies has increased, along with the morbidity of the procedure. Performing a "pre-pathological" evaluation of biopsy cores during the biopsy procedure would be of significant help to determine the nature of targeted areas and guide the number of biopsies to perform.

We hypothesize that FFOCT imaging of prostate biopsy cores would allow a cancer detection rate not statistically different from pathological analysis.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
45 Years to 75 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •- Patient aged 45 to 75 years old included
  • •- PSA level 4.0 ng/mL
  • •- Patient referred for trans rectal ultrasound-guided prostate biopsy with additional MRI-targeted biopsies
  • •- Patient no opposed to participate in the study
  • •Patient affiliated to the French National Social Security System

Exclusion Criteria

  • •Known prostate cancer
  • •Patients unable to understand the course of the study

Arms & Interventions

Full Field Optical Coherence Tomography (FFOCT) procedure

Intervention: Full Field Optical Coherence Tomography (FFOCT) procedure (Procedure)

Outcomes

Primary Outcomes

To evaluate the diagnosis performance of FFOCT for cancer detection in patients undergoing TRUS prostate biopsy, as compared to standard pathological evaluation

Time Frame: One day (biopsy procedure)

Presence or absence of prostate cancer on pathological examination of prostate biopsy cores

Secondary Outcomes

  • To evaluate the value of FFOCT for cancer characterization on prostate biopsy cores(One day (biopsy procedure))
  • To evaluate the reproducibility of FFOCT evaluation for cancer detection on prostate biopsy cores(One day (biopsy procedure))
  • To evaluate the learning curve of FFOCT evaluation on prostate biopsy cores(One day (biopsy procedure))
  • To evaluate the predictive values of FFOCT for cancer detection on prostate TRUS biopsy(One day (biopsy procedure))
  • To evaluate FFOCT procedure time(One day (biopsy procedure))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials